Thyroid Tablets Recall: Vitruvias Therapeutics 1/2 Grain (30 mg)
Announced 2026-09-23 · FDA
FDA recalls Thyroid Tablets, USP, 1/2 Grain (30 mg) due to a superpotent drug. The recall covers 1955 bottles distributed nationwide in the US; Lot 504950, Exp 09/30/2026. Each tablet contains levothyroxine (T4) 19 mcg and liothyronine (T3) 4.5 mcg; Rx only; Product of USA.
| Brand | VITRUVIAS THERAPEUTICS INC |
|---|---|
| Product | Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet contains: levothyroxine (T4) 19 mcg, liothyronine (T3) 4.5 mcg, 100 Tablets, Rx only, Distributed by: Vitruvias Therapeutics, Auburn, AL 36830, Product of USA, NDC 69680-166-00. |
| Reason | Superpotent Drug |
| Severity | critical |
| Units affected | 1955 |
| Distribution | US Nationwide. |
| Agency | FDA |
WHAT YOU SHOULD DO
- Check your bottle's lot number and expiration (Lot 504950, Exp 09/30/2026).
- If you have an affected bottle, stop taking it and contact your healthcare provider for guidance.
- Return the product to your pharmacy or follow recall instructions for disposal or replacement; do not dispose in household trash unless instructed.
- If you have experienced adverse effects, contact your clinician or FDA MedWatch.
How to identify the recalled item
| Lot / date codes | Lot # 504950, Exp Date: 09/30/2026. |
|---|---|
| Lot / date codes | Lot # 504950, Exp Date: 09/30/2026. |
These are the identifiers FDA published for this recall. Most recall notices list no UPC or model number at all — if the code on your item is not shown here, that does not mean the item is excluded. Check the official notice, or contact the company.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.